[Antibiotic treatment in the perinatal period].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001437:Bacteriuria / Q000188:drug therapy; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy; D007612:Kanamycin / Q000627:therapeutic use; D008431:Maternal-Fetal Exchange; D008712:Methicillin / Q000627:therapeutic use; D009268:Nalidixic Acid / Q000097:blood / Q000627:therapeutic use; D009582:Nitrofurantoin / Q000097:blood / Q000627:therapeutic use; D007744:Obstetric Labor Complications / Q000382:microbiology; D007752:Obstetric Labor, Premature / Q000517:prevention & control; D010068:Oxacillin / Q000627:therapeutic use; D010400:Penicillin G / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D011704:Pyelonephritis / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013307:Streptomycin / Q000627:therapeutic use; D013421:Sulfamethoxypyridazine / Q000097:blood / Q000627:therapeutic use; D014470:Umbilical Cord / Q000382:microbiology; D014552:Urinary Tract Infections / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D009268:Nalidixic Acid; D007612:Kanamycin; D009582:Nitrofurantoin; D010400:Penicillin G; D008712:Methicillin; D013421:Sulfamethoxypyridazine; D010068:Oxacillin; D013307:Streptomycin
Perinatal antibiotika-behandling.